Philippine Government Updates Biotech Regulations to Speed Up ApprovalsMarch 9, 2022
The amendments in the Joint Department Circular No. 01 of 2021 by the Department of Science and Technology (DOST), Department of Agriculture (DA), Department of Environment and Natural Resources (DENR), Department of Health (DOH), and the Department of Interior and Local Government (DILG) were completed last year, after careful review of the JDC of 2016 that replaced the DA Administrative Order No. 8. One of the major changes in the new JDC is the compliance to the Republic Act No. 11032 or the “Ease of Doing Business and Efficient Government Service Delivery Act of 2018”. Thus, the revisions include simplified requirements and procedures and shortened processing time of applications. These amendments will reduce the red tape and expedite the approval process for products of modern biotechnology.
The JDC 2021 emphasizes that products of new breeding innovations that do not contain novel combinations of genetic materials obtained through modern biotechnology are not covered by the Circular.
Section 6 of the JDC states that the Bureau of Plant Industry will serve as the frontline institution to receive and process applications for field trial, commercial propagation, and direct use.
Another new feature of the Circular is the formation of a Joint Assessment Group (JAG) composed of qualified representatives or personnel from the Biosafety Committees and external technical experts. The JAG will be in charge of evaluating whether the regulated article does not pose greater risks to human health and the environment than its conventional counterpart. The Group, which will also include External Technical Experts from DOST, DA, DENR, and DOH will then make recommendations to the BPI Director.
Information on socio-economic, cultural, and ethical consideration may be submitted by the public during the public consultation process and this will be considered by the BPI Director, together with the technical evaluation on the safety of the product by the Joint Assessment Group, in the approval. For the field trial, a contingency plan in case of force majeure or intrusions in the field trial site has been added in the supporting documents required.
The period for public comments has been reduced from 60 days to 15 working days since the publication of the public information sheet on one newspaper of general circulation.
The JDC also indicated that regulation of stacked plants developed through conventional breeding of GM parental lines with approved individual events is not considered novel. Thus, the permit holder may request listing of their stacked events in the BPI Approval Registry for commercial propagation of direct use.
Download a copy of the Circular from the BPI website.
You might also like:
- Philippine Government Approves Revised GM Regulations
- Stakeholders in the Philippines Briefed on Science-based Framework for Regulation of Breeding Stacks
- Philippines Approves Bt Eggplant for Direct Use as Food, Feed, or for Processing
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Climate Change Affecting Billions of Lives; Impacts Irreversible, Latest IPCC Report Says
- Researchers Discover Imbalanced Expression of Genes Help Improve Wheat Yield
- AU Government Backs Research on Preventing Crop Frost Damage Using “Ice Nucleating” Bacteria
- Philippine Government Updates Biotech Regulations to Speed Up Approvals
- Potato Genome Decoded by German Research Team
- New Transporter Identified to Help Balance Zinc and Iron Homeostasis in Maize
- Researchers Explore Impact of Nanomaterials on Plants under Salt Stress
- Study Provides Clues in Breeding Stress-resistant Tortured Willow
Read the latest:
- Biotech Updates (February 1, 2023)
- Genome Editing Supplement (January 18, 2023)
- Gene Drive Supplement (January 25, 2023)
Subscribe to BU: